Corcept Therapeutics Incorporated (CORT)
USD 70.49
(-5.57%)
USD 70.49
(-5.57%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 475.89 Million USD | 20.03% |
| 2022 | 396.47 Million USD | 9.92% |
| 2021 | 360.69 Million USD | 3.56% |
| 2020 | 348.29 Million USD | 15.72% |
| 2019 | 300.98 Million USD | 22.33% |
| 2018 | 246.03 Million USD | 58.07% |
| 2017 | 155.64 Million USD | 96.37% |
| 2016 | 79.26 Million USD | 62.01% |
| 2015 | 48.92 Million USD | 90.6% |
| 2014 | 25.66 Million USD | 151.31% |
| 2013 | 10.21 Million USD | 217.6% |
| 2012 | 3.21 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 29 Thousand USD | -86.12% |
| 2008 | 209 Thousand USD | -56.64% |
| 2007 | 482 Thousand USD | 63.95% |
| 2006 | 294 Thousand USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 144.27 Million USD | 8.05% |
| 2024 Q2 | 161.27 Million USD | 11.78% |
| 2024 Q3 | 179.67 Million USD | 11.41% |
| 2023 Q2 | 116.14 Million USD | 11.39% |
| 2023 Q4 | 133.52 Million USD | 9.49% |
| 2023 FY | 475.89 Million USD | 20.03% |
| 2023 Q1 | 104.26 Million USD | 2.65% |
| 2023 Q3 | 121.95 Million USD | 5.01% |
| 2022 Q4 | 101.57 Million USD | 1.18% |
| 2022 Q3 | 100.38 Million USD | -1.65% |
| 2022 Q2 | 102.07 Million USD | 10.42% |
| 2022 FY | 396.47 Million USD | 9.92% |
| 2022 Q1 | 92.43 Million USD | -5.16% |
| 2021 FY | 360.69 Million USD | 3.56% |
| 2021 Q2 | 90.2 Million USD | 15.4% |
| 2021 Q4 | 97.46 Million USD | 2.75% |
| 2021 Q1 | 78.16 Million USD | -7.47% |
| 2021 Q3 | 94.85 Million USD | 5.16% |
| 2020 Q2 | 87.33 Million USD | -4.42% |
| 2020 FY | 348.29 Million USD | 15.72% |
| 2020 Q1 | 91.36 Million USD | 5.68% |
| 2020 Q3 | 85.11 Million USD | -2.54% |
| 2020 Q4 | 84.48 Million USD | -0.74% |
| 2019 Q4 | 86.45 Million USD | 8.0% |
| 2019 Q3 | 80.05 Million USD | 12.94% |
| 2019 FY | 300.98 Million USD | 22.33% |
| 2019 Q2 | 70.88 Million USD | 11.47% |
| 2019 Q1 | 63.58 Million USD | -2.55% |
| 2018 Q3 | 63.13 Million USD | 3.24% |
| 2018 Q4 | 65.25 Million USD | 3.35% |
| 2018 FY | 246.03 Million USD | 58.07% |
| 2018 Q1 | 56.48 Million USD | 8.37% |
| 2018 Q2 | 61.15 Million USD | 8.27% |
| 2017 Q3 | 41.78 Million USD | 20.13% |
| 2017 Q4 | 52.12 Million USD | 24.74% |
| 2017 FY | 155.64 Million USD | 96.37% |
| 2017 Q1 | 26.95 Million USD | 15.92% |
| 2017 Q2 | 34.78 Million USD | 29.05% |
| 2016 Q2 | 19.29 Million USD | 23.25% |
| 2016 Q1 | 15.65 Million USD | 7.22% |
| 2016 FY | 79.26 Million USD | 62.01% |
| 2016 Q4 | 23.25 Million USD | 10.42% |
| 2016 Q3 | 21.05 Million USD | 9.11% |
| 2015 Q3 | 13 Million USD | 12.92% |
| 2015 FY | 48.92 Million USD | 90.6% |
| 2015 Q4 | 14.6 Million USD | 12.29% |
| 2015 Q2 | 11.51 Million USD | 17.52% |
| 2015 Q1 | 9.8 Million USD | 11.92% |
| 2014 Q4 | 8.75 Million USD | 24.25% |
| 2014 FY | 25.66 Million USD | 151.31% |
| 2014 Q1 | 4.23 Million USD | 4.37% |
| 2014 Q2 | 5.63 Million USD | 33.21% |
| 2014 Q3 | 7.04 Million USD | 25.04% |
| 2013 Q3 | 2.59 Million USD | 38.87% |
| 2013 Q1 | 1.69 Million USD | 24.96% |
| 2013 FY | 10.21 Million USD | 217.6% |
| 2013 Q4 | 4.05 Million USD | 56.28% |
| 2013 Q2 | 1.86 Million USD | 10.08% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | 1.35 Million USD | 31.72% |
| 2012 Q3 | 1.03 Million USD | 24.67% |
| 2012 FY | 3.21 Million USD | 0.0% |
| 2012 Q2 | 827 Thousand USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | -100.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q1 | - USD | 100.0% |
| 2009 Q3 | 1.02 Million USD | 16983.33% |
| 2009 Q1 | 24 Thousand USD | -83.22% |
| 2009 FY | 29 Thousand USD | -86.12% |
| 2009 Q4 | -1000.00 USD | -100.1% |
| 2009 Q2 | 6000.00 USD | -75.0% |
| 2008 FY | 209 Thousand USD | -56.64% |
| 2008 Q4 | 143 Thousand USD | 116.67% |
| 2008 Q3 | 66 Thousand USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 Q1 | 108 Thousand USD | 47.95% |
| 2007 Q2 | 374 Thousand USD | 246.3% |
| 2007 Q3 | - USD | -100.0% |
| 2007 FY | 482 Thousand USD | 63.95% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q1 | 121 Thousand USD | 0.0% |
| 2006 Q4 | 73 Thousand USD | 0.0% |
| 2006 Q3 | - USD | -100.0% |
| 2006 Q2 | 100 Thousand USD | -17.36% |
| 2006 FY | 294 Thousand USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | -295.018% |
| Jaguar Health, Inc. | 7.72 Million USD | -6061.238% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 71770.783% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 9517980.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 68.648% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -297.396% |
| ContextLogic Inc. | 59 Million USD | -706.6% |
| MiMedx Group, Inc. | 266.84 Million USD | -78.342% |
| MEI Pharma, Inc. | 49.32 Million USD | -864.774% |
| AlloVir, Inc. | -398 Thousand USD | 119671.357% |
| Novavax, Inc. | 639.93 Million USD | 25.634% |
| Aptorum Group Limited | -1.11 Million USD | 42793.023% |
| Ardelyx, Inc. | 106.66 Million USD | -346.174% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -97.684% |
| Psyence Biomedical Ltd. | -240.00 USD | 198289266.667% |
| Vaxcyte, Inc. | -75 Million USD | 734.525% |
| Precigen, Inc. | 106 Thousand USD | -448856.604% |
| Pharming Group N.V. | 220.1 Million USD | -116.213% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -92306.602% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -47064.916% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -333.529% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 362.334% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 92194.375% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 467.429% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 1149.959% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 2264.434% |
| Acelyrin, Inc. | -115 Thousand USD | 413920.87% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 83443.958% |
| Senti Biosciences, Inc. | -2.68 Million USD | 17837.384% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -11647.569% |
| AbCellera Biologics Inc. | 38.02 Million USD | -1151.529% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 10018.591% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -396478.333% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -1533.746% |
| Chimerix, Inc. | 324 Thousand USD | -146780.864% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -95846.371% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 580458.537% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 1626.884% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 96826.423% |
| Elevation Oncology, Inc. | -39 Thousand USD | 1220341.026% |
| Alkermes plc | 1.37 Billion USD | 65.381% |
| Fortress Biotech, Inc. | 57.85 Million USD | -722.592% |
| Fortress Biotech, Inc. | 57.85 Million USD | -722.592% |
| Agenus Inc. | 139.61 Million USD | -240.862% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -2770.809% |
| Dyadic International, Inc. | 922.95 Thousand USD | -51461.882% |
| ImmuCell Corporation | 4.39 Million USD | -10724.915% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -2159.598% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 548.436% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 272283.616% |
| Immix Biopharma, Inc. | -5468.00 USD | 8703355.304% |
| Incyte Corporation | 3.44 Billion USD | 86.168% |
| IO Biotech, Inc. | -756 Thousand USD | 63048.942% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 1116.021% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 3662.655% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 1077075.649% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 584.533% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 865361.818% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -59238.404% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 90402.467% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -1519.403% |
| NextCure, Inc. | -3.68 Million USD | 13017.861% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -2399.05% |
| Onconetix, Inc. | -1.12 Million USD | 42320.438% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 1742.827% |
| Opthea Limited | 21.72 Thousand USD | -2190940.516% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 830253.857% |
| PureTech Health plc | -1.6 Million USD | 29787.711% |
| Pyxis Oncology, Inc. | -2 Million USD | 23894.7% |
| Seer, Inc. | 7.02 Million USD | -6672.364% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 4734892.558% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -5946.169% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 12172.253% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -112139.151% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -357.155% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -251.813% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 590.865% |
| ChromaDex Corporation | 50.78 Million USD | -837.168% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 205226.724% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 713.281% |
| CRISPR Therapeutics AG | 240.95 Million USD | -97.502% |
| Precision BioSciences, Inc. | 40.47 Million USD | -1075.86% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 584.8% |
| Innoviva, Inc. | 261.06 Million USD | -82.289% |
| Summit Therapeutics Inc. | -2.05 Million USD | 23314.341% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -10770.123% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -2108.837% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 401728.816% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 332193.984% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -78043.514% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -51.717% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -18388.5% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 938006.977% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 6804.621% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 100384.272% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 4576003.846% |
| Soligenix, Inc. | 97.31 Thousand USD | -488944.404% |
| Century Therapeutics, Inc. | -10.8 Million USD | 4502.757% |
| Kura Oncology, Inc. | -849 Thousand USD | 56153.475% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 809.189% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 323837.415% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -380.512% |
| Autolus Therapeutics plc | -4.86 Million USD | 9877.974% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -1049.891% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 283370.238% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -402.406% |
| GRI Bio, Inc. | 10.84 Million USD | -4289.761% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -18636.088% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 5578.232% |
| IGM Biosciences, Inc. | -211.66 Million USD | 324.839% |
| INmune Bio, Inc. | 155 Thousand USD | -306928.387% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -668.327% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 31693.762% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 73489.014% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 1625754.164% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -118281.592% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 23942.385% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 152142.812% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -403.799% |
| Verastem, Inc. | -62 Thousand USD | 767670.968% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -19443.901% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 182434.866% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -15621.639% |
| Histogen Inc. | 3.76 Million USD | -12526.532% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -82494.819% |
| Surrozen, Inc. | -27.23 Million USD | 1847.683% |
| Organovo Holdings, Inc. | -5.38 Million USD | 8930.841% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 39597.211% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 1955.554% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -2273.299% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 24035150.505% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -7744.722% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 709003.487% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -207.443% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -326301.92% |
| Apollomics, Inc. | 127 Thousand USD | -374619.685% |
| Amarin Corporation plc | 165.54 Million USD | -187.478% |
| Mesoblast Limited | -9.81 Million USD | 4948.64% |
| Turnstone Biologics Corp. | 16.5 Million USD | -2783.158% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 530.716% |
| Synaptogenix, Inc. | -6347.00 USD | 7498036.033% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 933225.49% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -194.918% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 72.925% |
| Better Therapeutics, Inc. | -2.72 Million USD | 17538.402% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 524.295% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -40.763% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 4171681.346% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 7702.141% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 43050.722% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -6403.06% |
| Insmed Incorporated | 239.63 Million USD | -98.591% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -13200.559% |
| OmniAb, Inc. | 14.66 Million USD | -3144.658% |
| Alector, Inc. | -95.05 Million USD | 600.662% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -278.833% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 1194.941% |
| Zai Lab Limited | 170.9 Million USD | -178.459% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -481.23% |
| Aura Biosciences, Inc. | -1.29 Million USD | 36848.571% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -365972.308% |
| Immunic, Inc. | -111 Thousand USD | 428833.333% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -2901.728% |
| Veracyte, Inc. | 248.14 Million USD | -91.778% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 106.809% |
| FibroGen, Inc. | 128.9 Million USD | -269.185% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 84378468.794% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 4179.015% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 85.997% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -122237.789% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -33.924% |
| TG Therapeutics, Inc. | 219.1 Million USD | -117.196% |
| Galecto, Inc. | -830 Thousand USD | 57436.627% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 34460.578% |
| Fortrea Holdings Inc. | 424 Million USD | -12.239% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 652.293% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 84031.922% |
| XBiotech Inc. | -1.74 Million USD | 27387.5% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 43050.722% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 1124.067% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 730.039% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -548.33% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -2732.197% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -22.325% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 1058.555% |
| Vaxxinity, Inc. | -2.23 Million USD | 21402.328% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -45.644% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 4302.584% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -1846.317% |
| NexImmune, Inc. | -1.02 Million USD | 46529.951% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -8812751.852% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 6797.397% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 95.789% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 712228.331% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 13501.69% |
| Ainos, Inc. | -253.73 Thousand USD | 187656.999% |
| Pluri Inc. | 322 Thousand USD | -147693.168% |
| Prothena Corporation plc | -129.2 Million USD | 468.336% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -843.786% |
| Celularity Inc. | 6.75 Million USD | -6945.063% |
| Rallybio Corporation | -150 Thousand USD | 317362.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 1559.484% |
| MeiraGTx Holdings plc | 287 Thousand USD | -165716.725% |
| Omeros Corporation | -69.77 Million USD | 782.002% |
| Humacyte, Inc. | -76.55 Million USD | 721.677% |
| Immunocore Holdings plc | 248.39 Million USD | -91.591% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 3237.28% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -662.871% |
| Blueprint Medicines Corporation | 236.58 Million USD | -101.152% |
| CalciMedica, Inc. | -58 Thousand USD | 820606.897% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 33472.651% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -1537.907% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 16833.263% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 1641.856% |
| Pulmatrix, Inc. | -8.22 Million USD | 5889.465% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 40774.701% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 119371.679% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 219.333% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -17045.719% |
| Cytokinetics, Incorporated | -322.59 Million USD | 247.521% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -55101.397% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 139658.358% |
| Vor Biopharma Inc. | -3.49 Million USD | 13728.121% |
| Roivant Sciences Ltd. | 109.23 Million USD | -335.661% |
| Evogene Ltd. | 1.39 Million USD | -33916.726% |
| ProKidney Corp. | -3.16 Million USD | 15117.166% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 1183.745% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -6840.265% |
| CorMedix Inc. | -205.56 Thousand USD | 231608.742% |
| BioLineRx Ltd. | 1.1 Million USD | -42850.722% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 704.917% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 1442203.03% |
| Atai Life Sciences N.V. | -5000.00 USD | 9517980.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 390628.398% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 495822.917% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 34361.627% |
| Sagimet Biosciences Inc. | 2 Million USD | -23694.7% |
| MediciNova, Inc. | 979.7 Thousand USD | -48475.234% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 664.397% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 503398.609% |
| GeoVax Labs, Inc. | -20.72 Million USD | 2396.701% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -94.612% |
| Biomea Fusion, Inc. | -4.2 Million USD | 11428.112% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 45.446% |
| Mereo BioPharma Group plc | 7.42 Million USD | -6308.484% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 153614.194% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 3965883.333% |
| Absci Corporation | -41.84 Million USD | 1237.169% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 9517980.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 723.118% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 19437.424% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -122.656% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 50673.22% |
| Allakos Inc. | -6.14 Million USD | 7849.454% |
| Imunon, Inc. | -720 Thousand USD | 66195.93% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 789.741% |
| BioAtla, Inc. | -103.73 Million USD | 558.777% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 4171681.346% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 267456.18% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 295.987% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 153120.579% |
| XOMA Corporation | 3.86 Million USD | -12225.667% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 779.024% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -3116.804% |
| aTyr Pharma, Inc. | -2.38 Million USD | 20028.559% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -3719.374% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 1641113.793% |
| Viridian Therapeutics, Inc. | -1 Million USD | 47311.706% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -3660722976.923% |
| Akari Therapeutics, Plc | -4000.00 USD | 11897450.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 25.279% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -244314.2% |
| UroGen Pharma Ltd. | 73.35 Million USD | -548.781% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 1882.775% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -4098900.861% |
| Orgenesis Inc. | -5.72 Million USD | 8412.559% |
| Entera Bio Ltd. | -56 Thousand USD | 849910.714% |
| GH Research PLC | -315 Thousand USD | 151177.46% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 251895.767% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 90746.476% |
| Xencor, Inc. | -85.26 Million USD | 658.168% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 215459.065% |
| Replimune Group, Inc. | -2.65 Million USD | 18024.444% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 47630.652% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -167.591% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -244314.2% |
| Portage Biotech Inc. | -54 Thousand USD | 881385.185% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 503398.609% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 126331.83% |
| OncoCyte Corporation | 413 Thousand USD | -115128.571% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 10587285.762% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 214366766.667% |
| Purple Biotech Ltd. | -196 Thousand USD | 242903.061% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -5206.579% |
| scPharmaceuticals Inc. | 9.78 Million USD | -4764.997% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 4656.208% |
| HilleVax, Inc. | -2.15 Million USD | 22173.006% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 490712.371% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 3171880.858% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 71341.617% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 2069204.348% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 6340146.042% |
| Savara Inc. | -44.26 Million USD | 1175.175% |
| Curis, Inc. | 9.81 Million USD | -4750.617% |
| Daré Bioscience, Inc. | 2.76 Million USD | -17083.254% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 381461.99% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 27624.234% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 208825.439% |
| BeiGene, Ltd. | 2.07 Billion USD | 77.108% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 17121.138% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 219.074% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -739.497% |
| Erasca, Inc. | -3.73 Million USD | 12851.715% |
| bluebird bio, Inc. | -4.03 Million USD | 11908.784% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1686590.892% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 75.01% |
| DBV Technologies S.A. | 15.72 Million USD | -2925.776% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1686590.892% |
| Moderna, Inc. | 2.15 Billion USD | 77.917% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 52110.273% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -5844.217% |
| Molecular Templates, Inc. | 50.39 Million USD | -844.328% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 88886.194% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -255.708% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 7748.57% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 1309.603% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 528.24% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 13363.489% |
| MacroGenics, Inc. | 50.52 Million USD | -841.861% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 7904.1% |
| Prime Medicine, Inc. | -147.9 Million USD | 421.757% |
| Aditxt, Inc. | -111.66 Thousand USD | 426299.176% |
| Adagene Inc. | 18.11 Million USD | -2527.58% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -97419.262% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -239.435% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -201.512% |
| SciSparc Ltd. | 2.19 Million USD | -21570.947% |
| Vericel Corporation | 135.57 Million USD | -251.016% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1899952.29% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 1536133.826% |
| Generation Bio Co. | -73.91 Million USD | 743.874% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 109000.229% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -771.298% |
| Invivyd, Inc. | -2.02 Million USD | 23566.174% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 258.188% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 460176.568% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -393.83% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -384.183% |
| ADMA Biologics, Inc. | 88.21 Million USD | -439.452% |
| Clene Inc. | 533 Thousand USD | -89185.929% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -1873.912% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 49827.691% |
| GeoVax Labs, Inc. | -20.72 Million USD | 2396.701% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -23838.33% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 245007.264% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -855.515% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 6810.293% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 57025.12% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -470.514% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -650810.931% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -795.177% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 374.785% |
| Trevena, Inc. | 1.45 Million USD | -32607.491% |
| Surrozen, Inc. | -27.23 Million USD | 1847.683% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 134914.164% |
| Cingulate Inc. | -582.91 Thousand USD | 81739.956% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 1535241.935% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 2515.828% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 6286678.6% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 54117.48% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 30.088% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 48267.409% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 844752.302% |
| Kronos Bio, Inc. | 1.37 Million USD | -34586.152% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 986.77% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 163077.397% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 97556.555% |
| ImmunityBio, Inc. | -17.89 Million USD | 2760.112% |
| Korro Bio, Inc. | -3.63 Million USD | 13210.028% |
| Kineta, Inc. | 5.43 Million USD | -8659.323% |
| BioVie Inc. | -229.37 Thousand USD | 207572.414% |
| Codexis, Inc. | 57.33 Million USD | -730.038% |
| Celularity Inc. | 6.75 Million USD | -6945.063% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -11758.809% |
| Celcuity Inc. | -142.77 Thousand USD | 333424.461% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -940587.883% |
| Cibus, Inc. | 1.42 Million USD | -33366.526% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 127344.385% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 2176.417% |
| IN8bio, Inc. | -2.5 Million USD | 19128.149% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1934.1% |
| Annexon, Inc. | -3.26 Million USD | 14666.697% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 23382.485% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 1240.221% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -74258.438% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 38.871% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -175.155% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 25147.053% |
| Arcellx, Inc. | 108.27 Million USD | -339.507% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 1570.215% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -500.846% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 2349.877% |
| Moolec Science SA | -143.3 Thousand USD | 332184.714% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 1224.566% |
| Geron Corporation | -123.5 Million USD | 485.33% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -14378.065% |
| Royalty Pharma plc | 1.79 Billion USD | 73.472% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 778.976% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 13175459.911% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -205566.599% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 527.14% |
| Humacyte, Inc. | -76.55 Million USD | 721.677% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 50237.699% |
| 89bio, Inc. | -273 Thousand USD | 174420.147% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 37959.507% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 56219.575% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 387005.691% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -42428.508% |
| Notable Labs, Ltd. | 113 Thousand USD | -421045.133% |
| Liquidia Corporation | 14.6 Million USD | -3159.548% |
| Mustang Bio, Inc. | -2.22 Million USD | 21488.494% |
| Immunovant, Inc. | -231 Thousand USD | 206114.719% |
| Quantum-Si incorporated | 488 Thousand USD | -97419.262% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 956.556% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 1586413.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -25458.217% |
| Acasti Pharma Inc. | -11 Thousand USD | 4326409.091% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 232677.938% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 73489.014% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 384.095% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -41844.508% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 125006.562% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 24405.107% |
| PepGen Inc. | -1.18 Million USD | 40293.75% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 374819.685% |
| United Therapeutics Corporation | 2.07 Billion USD | 77.01% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 2178.412% |
| Solid Biosciences Inc. | -76.56 Million USD | 721.572% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 576361.458% |
| Immuneering Corporation | -764.13 Thousand USD | 62378.541% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -718078.8% |
| Belite Bio, Inc | -399 Thousand USD | 119371.679% |
| XOMA Corporation | 3.86 Million USD | -12225.667% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 2475.195% |
| Bionomics Limited | -434.44 Thousand USD | 109639.67% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 44410.428% |
| uniQure N.V. | 2.21 Million USD | -21385.056% |
| Cassava Sciences, Inc. | -89.42 Million USD | 632.183% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 616.888% |
| Forte Biosciences, Inc. | -9000.00 USD | 5287811.111% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 57093.293% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 109000.229% |
| Altimmune, Inc. | -65.37 Million USD | 827.967% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -31.452% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 44410.428% |
| Compugen Ltd. | 31.45 Million USD | -1412.936% |
| Peak Bio, Inc. | 367.76 Thousand USD | -129300.249% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -1841.157% |
| Benitec Biopharma Inc. | 108 Thousand USD | -440542.593% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 610220.513% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 39658.936% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 26219.319% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 400010.924% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 39658.936% |
| Instil Bio, Inc. | -4.75 Million USD | 10106.182% |
| argenx SE | 1.1 Billion USD | 57.068% |
| Immunome, Inc. | -8.9 Million USD | 5442.921% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 25279.577% |
| Verona Pharma plc | -679.62 Thousand USD | 70123.13% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 272039.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | 20053.627% |
| CervoMed Inc. | -1.29 Million USD | 36887.575% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 19871.251% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 10062.194% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -19159.166% |
| Moolec Science SA | -143.3 Thousand USD | 332184.714% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 116732.11% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 17913.551% |
| AnaptysBio, Inc. | 14.78 Million USD | -3119.633% |
| Design Therapeutics, Inc. | -537 Thousand USD | 88720.857% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 111550.585% |
| NeurAxis, Inc. | 2.15 Million USD | -21965.8% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -22075.862% |
| Lumos Pharma, Inc. | 2 Million USD | -23611.709% |
| Achilles Therapeutics plc | -4.73 Million USD | 10158.49% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 272039.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 450437.355% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -1403.199% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -55101.397% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 46213.76% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 1144.819% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -1106630.233% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 57994.647% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 3616865.466% |
| Palisade Bio, Inc. | 246 Thousand USD | -193352.846% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 1442203.03% |
| Beam Therapeutics Inc. | -59.67 Million USD | 897.516% |
| Neurogene Inc. | -3.26 Million USD | 14689.025% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -241.547% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 12989.87% |
| Sesen Bio, Inc. | 40 Million USD | -1089.735% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 160333.67% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 11917.473% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 5074.848% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -3279.929% |
| Athira Pharma, Inc. | -969 Thousand USD | 49211.868% |
| Vaccinex, Inc. | -16 Million USD | 3073.594% |
| HCW Biologics Inc. | -574.82 Thousand USD | 82889.515% |
| XOMA Corporation | 3.86 Million USD | -12225.667% |
| Nektar Therapeutics | 53.47 Million USD | -789.887% |
| Arvinas, Inc. | 71.8 Million USD | -562.805% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 670.199% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 858.095% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 147893.168% |
| Rezolute, Inc. | -36 Thousand USD | 1322027.778% |
| Clene Inc. | 533 Thousand USD | -89185.929% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 37063495.639% |
| BeyondSpring Inc. | 1.75 Million USD | -27078.412% |
| Synlogic, Inc. | -1.92 Million USD | 24834.615% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 1286300.0% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 7615.698% |
| Peak Bio, Inc. | 367.76 Thousand USD | -129300.249% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 2609.592% |
| Krystal Biotech, Inc. | 47.6 Million USD | -899.672% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -237.296% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -9370.527% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 18479.828% |
| MannKind Corporation | 136.19 Million USD | -249.431% |
| Ikena Oncology, Inc. | -50.49 Million USD | 1042.514% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -337.346% |
| Gossamer Bio, Inc. | -4.38 Million USD | 10952.771% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 188946.825% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 9517980.0% |
| Legend Biotech Corporation | 140.92 Million USD | -237.684% |
| Mural Oncology plc | -2.56 Million USD | 18638.917% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 86469.147% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 475994.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -2193.023% |
| REGENXBIO Inc. | 53.02 Million USD | -797.422% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 8983.67% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 247478.298% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 27576.559% |
| Vaxart, Inc. | -60.76 Million USD | 883.197% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 181199.779% |
| Cellectis S.A. | 18 Thousand USD | -2643755.556% |
| Longeveron Inc. | 221 Thousand USD | -215236.652% |
| Repare Therapeutics Inc. | -80.07 Million USD | 694.347% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 56.46% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 36876.971% |
| Revolution Medicines, Inc. | -399.66 Million USD | 219.074% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 1359797.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -971112.245% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 94.471% |
| Denali Therapeutics Inc. | -93.34 Million USD | 609.823% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1899952.29% |
| Veru Inc. | 7.56 Million USD | -6189.962% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 315261.589% |
| Cingulate Inc. | -582.91 Thousand USD | 81739.956% |
| Passage Bio, Inc. | -3.72 Million USD | 12889.411% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 3951395.251% |
| Exicure, Inc. | -1.42 Million USD | 33543.008% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 124354.308% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -17506.141% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 92925.669% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -598.55% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 318196.078% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 903.794% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -121612.02% |
| OmniAb, Inc. | 14.66 Million USD | -3144.658% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -2280.303% |
| Lipocine Inc. | -2.85 Million USD | 16793.244% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 25921.704% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 8441.7% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 31693.762% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -531.863% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 732244.615% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -464.551% |
| Ocugen, Inc. | -33.53 Million USD | 1519.012% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 15150.411% |
| Q32 Bio Inc. | 578 Thousand USD | -82234.602% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 179682.642% |
| Alumis Inc. Common Stock | -1.28 Million USD | 37163.396% |
| Equillium, Inc. | 35.95 Million USD | -1223.472% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 27978.969% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -94949.722% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 11511807.789% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 183842.857% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -112481.143% |
| Dominari Holdings Inc. | 2.03 Million USD | -23239.578% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 259483.772% |
| vTv Therapeutics Inc. | -13.59 Million USD | 3600.508% |
| Bio-Techne Corporation | 773.07 Million USD | 38.441% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -2647.815% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -3.279% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 40809.495% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 2084.545% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -3968.513% |
| Nkarta, Inc. | -5.86 Million USD | 8208.605% |
| BioCardia, Inc. | -7.24 Million USD | 6664.961% |
| Iterum Therapeutics plc | -1.75 Million USD | 27293.943% |